Vivos Therapeutics (VVOS) EPS (Diluted) (2022 - 2026)

Vivos Therapeutics (VVOS) EPS (Diluted) (2022 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Abbott Laboratories 182.69 Bn 175.40 Bn 6.27 Bn 0.62
2 Stryker 128.95 Bn 126.07 Bn 3.81 Bn 1.93
3 Medtronic 108.07 Bn 98.85 Bn 6.41 Bn 0.98
4 Boston Scientific 67.93 Bn 66.47 Bn 3.61 Bn 0.90
5 Edwards Lifesciences 48.11 Bn 44.44 Bn 1.29 Bn -
6 Dexcom 28.33 Bn 27.21 Bn 750.30 Mn 0.51
7 GE HealthCare Technologies 27.89 Bn 25.60 Bn 1.98 Bn 0.90
8 Smith & Nephew 26.99 Bn 26.42 Bn - -
9 Koninklijke Philips 24.05 Bn 20.92 Bn 2.07 Bn 0.18
10 Vivos Therapeutics 5.91 Mn 3.80 Mn 3.06 Mn -0.52

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.52
Dec 31, 2025 -0.68
Sep 30, 2025 -0.49
Jun 30, 2025 -0.55
Mar 31, 2025 -0.45
Dec 31, 2024 -0.57
Sep 30, 2024 -0.40
Jun 30, 2024 -0.60
Mar 31, 2024 -1.63
Dec 31, 2023 7.68
Sep 30, 2023 -1.75
Jun 30, 2023 -4.62
Mar 31, 2023 -1.72
Dec 31, 2022 -6.61
Sep 30, 2022 -6.40
Jun 30, 2022 -8.23